Kev Dhaliwal
Oprichter bij Edinburgh Molecular Imaging Ltd.
Profiel
Kev Dhaliwal is the founder of Edinburgh Molecular Imaging Ltd., which was founded in 2014.
Currently, he holds a position as a Non-Executive Director at CodeBase Ltd.
Actieve functies van Kev Dhaliwal
| Bedrijven | Functie | Begin |
|---|---|---|
Edinburgh Molecular Imaging Ltd.
 Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom. | Oprichter | 01-02-2014 |
CodeBase Ltd.
 CodeBase Ltd. Information Technology ServicesTechnology Services Codebase Ltd. provides technology incubator services. The company was founded by Jamie Coleman and Stephen Coleman in November 21, 2012 and is headquartered in Edinburgh, the United Kingdom. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
CodeBase Ltd.
CodeBase Ltd. Information Technology ServicesTechnology Services Codebase Ltd. provides technology incubator services. The company was founded by Jamie Coleman and Stephen Coleman in November 21, 2012 and is headquartered in Edinburgh, the United Kingdom. | Technology Services |
Edinburgh Molecular Imaging Ltd.
Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |